1. Home
  2. NVCR vs UVV Comparison

NVCR vs UVV Comparison

Compare NVCR & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • UVV
  • Stock Information
  • Founded
  • NVCR 2000
  • UVV 1886
  • Country
  • NVCR Switzerland
  • UVV United States
  • Employees
  • NVCR N/A
  • UVV N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • UVV Farming/Seeds/Milling
  • Sector
  • NVCR Health Care
  • UVV Industrials
  • Exchange
  • NVCR Nasdaq
  • UVV Nasdaq
  • Market Cap
  • NVCR 1.4B
  • UVV 1.3B
  • IPO Year
  • NVCR 2015
  • UVV N/A
  • Fundamental
  • Price
  • NVCR $13.77
  • UVV $53.62
  • Analyst Decision
  • NVCR Buy
  • UVV
  • Analyst Count
  • NVCR 7
  • UVV 0
  • Target Price
  • NVCR $28.79
  • UVV N/A
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • UVV 165.1K
  • Earning Date
  • NVCR 10-30-2025
  • UVV 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • UVV 6.14%
  • EPS Growth
  • NVCR N/A
  • UVV N/A
  • EPS
  • NVCR N/A
  • UVV 4.11
  • Revenue
  • NVCR $630,160,000.00
  • UVV $2,943,996,000.00
  • Revenue This Year
  • NVCR $6.68
  • UVV $1.52
  • Revenue Next Year
  • NVCR $7.01
  • UVV $0.97
  • P/E Ratio
  • NVCR N/A
  • UVV $13.00
  • Revenue Growth
  • NVCR 14.58
  • UVV 4.11
  • 52 Week Low
  • NVCR $10.87
  • UVV $49.40
  • 52 Week High
  • NVCR $34.13
  • UVV $67.33
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.39
  • UVV 44.60
  • Support Level
  • NVCR $13.57
  • UVV $52.26
  • Resistance Level
  • NVCR $14.58
  • UVV $53.77
  • Average True Range (ATR)
  • NVCR 0.64
  • UVV 0.80
  • MACD
  • NVCR -0.05
  • UVV -0.00
  • Stochastic Oscillator
  • NVCR 49.59
  • UVV 47.55

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

Share on Social Networks: